Review




Structured Review

Metabolon Inc non targeted metabolomics analysis
<t>Metabolomics</t> analysis. (A) Metabolite volcano plot. The x-axis displays the log2 of fold change, while the y-axis shows the -log10 of the significance P-value. Significantly differential metabolites: those meeting FC > 2 and P value < 0.05 are depicted in orange; those meeting FC < 0.5 and P value < 0.05 are depicted in purple. Non-significant metabolites are depicted in grey. (B) Differential metabolite clustering heatmap. Relative abundance is depicted by color intensity: red indicates higher expression, blue lower expression. Columns represent samples, rows denote metabolite names. The clustering tree on the left displays differentiated metabolites. (C) Venn diagram. The sum of numbers within each circle represents the total differentiated metabolites for that comparison pair. Overlapping areas indicate metabolites common to both comparison groups. (D) Enrichment factor plot: Enrichment is measured by the Rich factor, P-value, and the number of metabolites enriched in this pathway. The Rich factor denotes the ratio of enriched differentially expressed metabolites to annotated metabolites in the pathway. A higher Rich factor indicates greater enrichment. P-values typically range from 0 to 0.05; values closer to zero denote more significant enrichment. Each point represents a metabolic pathway, with the x-axis displaying Rich factor values for different pathways and the y-axis showing the enriched pathways. Dots indicate the number of metabolites within each pathway. Color corresponds to P-value significance.
Non Targeted Metabolomics Analysis, supplied by Metabolon Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+targeted+metabolomics+analysis/pmc13054027-67-16-14?v=Metabolon+Inc
Average 86 stars, based on 1 article reviews
non targeted metabolomics analysis - by Bioz Stars, 2026-07
86/100 stars

Images

1) Product Images from "Mechanism of Scutellaria baicalensis extracellular vesicles in attenuating Mycoplasma gallisepticum -induced inflammation via TRPC1 - STIM1/ORAI1 channel inhibition"

Article Title: Mechanism of Scutellaria baicalensis extracellular vesicles in attenuating Mycoplasma gallisepticum -induced inflammation via TRPC1 - STIM1/ORAI1 channel inhibition

Journal: Poultry Science

doi: 10.1016/j.psj.2026.106773

Metabolomics analysis. (A) Metabolite volcano plot. The x-axis displays the log2 of fold change, while the y-axis shows the -log10 of the significance P-value. Significantly differential metabolites: those meeting FC > 2 and P value < 0.05 are depicted in orange; those meeting FC < 0.5 and P value < 0.05 are depicted in purple. Non-significant metabolites are depicted in grey. (B) Differential metabolite clustering heatmap. Relative abundance is depicted by color intensity: red indicates higher expression, blue lower expression. Columns represent samples, rows denote metabolite names. The clustering tree on the left displays differentiated metabolites. (C) Venn diagram. The sum of numbers within each circle represents the total differentiated metabolites for that comparison pair. Overlapping areas indicate metabolites common to both comparison groups. (D) Enrichment factor plot: Enrichment is measured by the Rich factor, P-value, and the number of metabolites enriched in this pathway. The Rich factor denotes the ratio of enriched differentially expressed metabolites to annotated metabolites in the pathway. A higher Rich factor indicates greater enrichment. P-values typically range from 0 to 0.05; values closer to zero denote more significant enrichment. Each point represents a metabolic pathway, with the x-axis displaying Rich factor values for different pathways and the y-axis showing the enriched pathways. Dots indicate the number of metabolites within each pathway. Color corresponds to P-value significance.
Figure Legend Snippet: Metabolomics analysis. (A) Metabolite volcano plot. The x-axis displays the log2 of fold change, while the y-axis shows the -log10 of the significance P-value. Significantly differential metabolites: those meeting FC > 2 and P value < 0.05 are depicted in orange; those meeting FC < 0.5 and P value < 0.05 are depicted in purple. Non-significant metabolites are depicted in grey. (B) Differential metabolite clustering heatmap. Relative abundance is depicted by color intensity: red indicates higher expression, blue lower expression. Columns represent samples, rows denote metabolite names. The clustering tree on the left displays differentiated metabolites. (C) Venn diagram. The sum of numbers within each circle represents the total differentiated metabolites for that comparison pair. Overlapping areas indicate metabolites common to both comparison groups. (D) Enrichment factor plot: Enrichment is measured by the Rich factor, P-value, and the number of metabolites enriched in this pathway. The Rich factor denotes the ratio of enriched differentially expressed metabolites to annotated metabolites in the pathway. A higher Rich factor indicates greater enrichment. P-values typically range from 0 to 0.05; values closer to zero denote more significant enrichment. Each point represents a metabolic pathway, with the x-axis displaying Rich factor values for different pathways and the y-axis showing the enriched pathways. Dots indicate the number of metabolites within each pathway. Color corresponds to P-value significance.

Techniques Used: Expressing, Comparison



Similar Products

86
Metabolon Inc non targeted metabolomics analysis
<t>Metabolomics</t> analysis. (A) Metabolite volcano plot. The x-axis displays the log2 of fold change, while the y-axis shows the -log10 of the significance P-value. Significantly differential metabolites: those meeting FC > 2 and P value < 0.05 are depicted in orange; those meeting FC < 0.5 and P value < 0.05 are depicted in purple. Non-significant metabolites are depicted in grey. (B) Differential metabolite clustering heatmap. Relative abundance is depicted by color intensity: red indicates higher expression, blue lower expression. Columns represent samples, rows denote metabolite names. The clustering tree on the left displays differentiated metabolites. (C) Venn diagram. The sum of numbers within each circle represents the total differentiated metabolites for that comparison pair. Overlapping areas indicate metabolites common to both comparison groups. (D) Enrichment factor plot: Enrichment is measured by the Rich factor, P-value, and the number of metabolites enriched in this pathway. The Rich factor denotes the ratio of enriched differentially expressed metabolites to annotated metabolites in the pathway. A higher Rich factor indicates greater enrichment. P-values typically range from 0 to 0.05; values closer to zero denote more significant enrichment. Each point represents a metabolic pathway, with the x-axis displaying Rich factor values for different pathways and the y-axis showing the enriched pathways. Dots indicate the number of metabolites within each pathway. Color corresponds to P-value significance.
Non Targeted Metabolomics Analysis, supplied by Metabolon Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+targeted+metabolomics+analysis/pmc13054027-67-16-14?v=Metabolon+Inc
Average 86 stars, based on 1 article reviews
non targeted metabolomics analysis - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Shanghai Genechem Ltd non targeted sperm metabolomics analysis
<t>Metabolomics</t> analysis. (A) Metabolite volcano plot. The x-axis displays the log2 of fold change, while the y-axis shows the -log10 of the significance P-value. Significantly differential metabolites: those meeting FC > 2 and P value < 0.05 are depicted in orange; those meeting FC < 0.5 and P value < 0.05 are depicted in purple. Non-significant metabolites are depicted in grey. (B) Differential metabolite clustering heatmap. Relative abundance is depicted by color intensity: red indicates higher expression, blue lower expression. Columns represent samples, rows denote metabolite names. The clustering tree on the left displays differentiated metabolites. (C) Venn diagram. The sum of numbers within each circle represents the total differentiated metabolites for that comparison pair. Overlapping areas indicate metabolites common to both comparison groups. (D) Enrichment factor plot: Enrichment is measured by the Rich factor, P-value, and the number of metabolites enriched in this pathway. The Rich factor denotes the ratio of enriched differentially expressed metabolites to annotated metabolites in the pathway. A higher Rich factor indicates greater enrichment. P-values typically range from 0 to 0.05; values closer to zero denote more significant enrichment. Each point represents a metabolic pathway, with the x-axis displaying Rich factor values for different pathways and the y-axis showing the enriched pathways. Dots indicate the number of metabolites within each pathway. Color corresponds to P-value significance.
Non Targeted Sperm Metabolomics Analysis, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+targeted+metabolomics+analysis/pm42167576-355-0-7?v=Shanghai+Genechem+Ltd
Average 86 stars, based on 1 article reviews
non targeted sperm metabolomics analysis - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Beijing Biomarker Technologies Co Ltd non targeted metabolomic analysis
<t>Metabolomics</t> analysis. (A) Metabolite volcano plot. The x-axis displays the log2 of fold change, while the y-axis shows the -log10 of the significance P-value. Significantly differential metabolites: those meeting FC > 2 and P value < 0.05 are depicted in orange; those meeting FC < 0.5 and P value < 0.05 are depicted in purple. Non-significant metabolites are depicted in grey. (B) Differential metabolite clustering heatmap. Relative abundance is depicted by color intensity: red indicates higher expression, blue lower expression. Columns represent samples, rows denote metabolite names. The clustering tree on the left displays differentiated metabolites. (C) Venn diagram. The sum of numbers within each circle represents the total differentiated metabolites for that comparison pair. Overlapping areas indicate metabolites common to both comparison groups. (D) Enrichment factor plot: Enrichment is measured by the Rich factor, P-value, and the number of metabolites enriched in this pathway. The Rich factor denotes the ratio of enriched differentially expressed metabolites to annotated metabolites in the pathway. A higher Rich factor indicates greater enrichment. P-values typically range from 0 to 0.05; values closer to zero denote more significant enrichment. Each point represents a metabolic pathway, with the x-axis displaying Rich factor values for different pathways and the y-axis showing the enriched pathways. Dots indicate the number of metabolites within each pathway. Color corresponds to P-value significance.
Non Targeted Metabolomic Analysis, supplied by Beijing Biomarker Technologies Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+targeted+metabolomics+analysis/pm41829786-190-0-6?v=Beijing+Biomarker+Technologies+Co+Ltd
Average 86 stars, based on 1 article reviews
non targeted metabolomic analysis - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Novogene non targeted metabolomic analysis
<t>Metabolomics</t> analysis. (A) Metabolite volcano plot. The x-axis displays the log2 of fold change, while the y-axis shows the -log10 of the significance P-value. Significantly differential metabolites: those meeting FC > 2 and P value < 0.05 are depicted in orange; those meeting FC < 0.5 and P value < 0.05 are depicted in purple. Non-significant metabolites are depicted in grey. (B) Differential metabolite clustering heatmap. Relative abundance is depicted by color intensity: red indicates higher expression, blue lower expression. Columns represent samples, rows denote metabolite names. The clustering tree on the left displays differentiated metabolites. (C) Venn diagram. The sum of numbers within each circle represents the total differentiated metabolites for that comparison pair. Overlapping areas indicate metabolites common to both comparison groups. (D) Enrichment factor plot: Enrichment is measured by the Rich factor, P-value, and the number of metabolites enriched in this pathway. The Rich factor denotes the ratio of enriched differentially expressed metabolites to annotated metabolites in the pathway. A higher Rich factor indicates greater enrichment. P-values typically range from 0 to 0.05; values closer to zero denote more significant enrichment. Each point represents a metabolic pathway, with the x-axis displaying Rich factor values for different pathways and the y-axis showing the enriched pathways. Dots indicate the number of metabolites within each pathway. Color corresponds to P-value significance.
Non Targeted Metabolomic Analysis, supplied by Novogene, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+targeted+metabolomics+analysis/pm41753588-72-9-14?v=Novogene
Average 86 stars, based on 1 article reviews
non targeted metabolomic analysis - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Beijing Genomics Institute Shenzhen non targeted metabolomics analysis
Schematic diagram of integrated multi-omics data analysis workflow for children with ASD. This figure illustrates the integrated multi-omics analysis framework established in this study to investigate the core mechanisms of gut-brain axis dysfunction in children with ASD, encompassing clinical phenotypes, genomics, microbiomics, and <t>metabolomics.</t>
Non Targeted Metabolomics Analysis, supplied by Beijing Genomics Institute Shenzhen, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+targeted+metabolomics+analysis/pmc12913364-126-0-6?v=Beijing+Genomics+Institute+Shenzhen
Average 86 stars, based on 1 article reviews
non targeted metabolomics analysis - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Shanghai Genechem Ltd non targeted metabolomics analysis
<t>Metabonomic</t> pathway of significantly different metabolites. (A) Heatmap of tear differentially expressed metabolites among both groups. (B,C) Category histogram and KEGG enrichment analysis of differentially expressed metabolites in tears.
Non Targeted Metabolomics Analysis, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+targeted+metabolomics+analysis/pmc12592072-56-10-17?v=Shanghai+Genechem+Ltd
Average 86 stars, based on 1 article reviews
non targeted metabolomics analysis - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Sangon Biotech non target metabolome analysis
<t>Metabonomic</t> pathway of significantly different metabolites. (A) Heatmap of tear differentially expressed metabolites among both groups. (B,C) Category histogram and KEGG enrichment analysis of differentially expressed metabolites in tears.
Non Target Metabolome Analysis, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+targeted+metabolomics+analysis/pm40648040-319-1-7?v=Sangon+Biotech
Average 86 stars, based on 1 article reviews
non target metabolome analysis - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

Image Search Results


Metabolomics analysis. (A) Metabolite volcano plot. The x-axis displays the log2 of fold change, while the y-axis shows the -log10 of the significance P-value. Significantly differential metabolites: those meeting FC > 2 and P value < 0.05 are depicted in orange; those meeting FC < 0.5 and P value < 0.05 are depicted in purple. Non-significant metabolites are depicted in grey. (B) Differential metabolite clustering heatmap. Relative abundance is depicted by color intensity: red indicates higher expression, blue lower expression. Columns represent samples, rows denote metabolite names. The clustering tree on the left displays differentiated metabolites. (C) Venn diagram. The sum of numbers within each circle represents the total differentiated metabolites for that comparison pair. Overlapping areas indicate metabolites common to both comparison groups. (D) Enrichment factor plot: Enrichment is measured by the Rich factor, P-value, and the number of metabolites enriched in this pathway. The Rich factor denotes the ratio of enriched differentially expressed metabolites to annotated metabolites in the pathway. A higher Rich factor indicates greater enrichment. P-values typically range from 0 to 0.05; values closer to zero denote more significant enrichment. Each point represents a metabolic pathway, with the x-axis displaying Rich factor values for different pathways and the y-axis showing the enriched pathways. Dots indicate the number of metabolites within each pathway. Color corresponds to P-value significance.

Journal: Poultry Science

Article Title: Mechanism of Scutellaria baicalensis extracellular vesicles in attenuating Mycoplasma gallisepticum -induced inflammation via TRPC1 - STIM1/ORAI1 channel inhibition

doi: 10.1016/j.psj.2026.106773

Figure Lengend Snippet: Metabolomics analysis. (A) Metabolite volcano plot. The x-axis displays the log2 of fold change, while the y-axis shows the -log10 of the significance P-value. Significantly differential metabolites: those meeting FC > 2 and P value < 0.05 are depicted in orange; those meeting FC < 0.5 and P value < 0.05 are depicted in purple. Non-significant metabolites are depicted in grey. (B) Differential metabolite clustering heatmap. Relative abundance is depicted by color intensity: red indicates higher expression, blue lower expression. Columns represent samples, rows denote metabolite names. The clustering tree on the left displays differentiated metabolites. (C) Venn diagram. The sum of numbers within each circle represents the total differentiated metabolites for that comparison pair. Overlapping areas indicate metabolites common to both comparison groups. (D) Enrichment factor plot: Enrichment is measured by the Rich factor, P-value, and the number of metabolites enriched in this pathway. The Rich factor denotes the ratio of enriched differentially expressed metabolites to annotated metabolites in the pathway. A higher Rich factor indicates greater enrichment. P-values typically range from 0 to 0.05; values closer to zero denote more significant enrichment. Each point represents a metabolic pathway, with the x-axis displaying Rich factor values for different pathways and the y-axis showing the enriched pathways. Dots indicate the number of metabolites within each pathway. Color corresponds to P-value significance.

Article Snippet: In collaboration with Paisen Bio (Shanghai, China; http://www.personalbio.cn/ ), cell samples were submitted to Metabolon for non-targeted metabolomics analysis.

Techniques: Expressing, Comparison

Schematic diagram of integrated multi-omics data analysis workflow for children with ASD. This figure illustrates the integrated multi-omics analysis framework established in this study to investigate the core mechanisms of gut-brain axis dysfunction in children with ASD, encompassing clinical phenotypes, genomics, microbiomics, and metabolomics.

Journal: Frontiers in Microbiology

Article Title: Integrated multi-omics analysis reveals the involvement of the gut-brain axis in children with autism

doi: 10.3389/fmicb.2026.1766850

Figure Lengend Snippet: Schematic diagram of integrated multi-omics data analysis workflow for children with ASD. This figure illustrates the integrated multi-omics analysis framework established in this study to investigate the core mechanisms of gut-brain axis dysfunction in children with ASD, encompassing clinical phenotypes, genomics, microbiomics, and metabolomics.

Article Snippet: Non-targeted metabolomics analysis was performed by Beijing Genomics Institution.

Techniques: Biomarker Discovery

Metabonomic pathway of significantly different metabolites. (A) Heatmap of tear differentially expressed metabolites among both groups. (B,C) Category histogram and KEGG enrichment analysis of differentially expressed metabolites in tears.

Journal: Frontiers in Medicine

Article Title: Changes in human tear metabolome following topical 0.05% cyclosporine A on primary Sjögren’s syndrome

doi: 10.3389/fmed.2025.1653585

Figure Lengend Snippet: Metabonomic pathway of significantly different metabolites. (A) Heatmap of tear differentially expressed metabolites among both groups. (B,C) Category histogram and KEGG enrichment analysis of differentially expressed metabolites in tears.

Article Snippet: Tears from one eye per patient were randomly chosen for non-targeted metabolomics analysis, which was conducted by Shanghai Genechem Co., Ltd. (Shanghai, China).

Techniques: